OR4F14P

Across TCGA pan-cancer cohorts, OR4F14P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR4F14P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher OR4F14P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4F14P expression acts as an unfavorable survival marker.

ESCA, UCEC, and PAAD are the cancer types where OR4F14P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	45	view →
UCEC	DFS	Tertile	All	0.624	0.842	.013	36	view →
PAAD	OS	Tertile	II,III,IV	0.131	0.586	.002	27	view →
OV	DFS	Tertile	IV	0.100	0.464	.044	18	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	18	view →
GBM	OS	Tertile	All	0.121	0.415	.042	9	view →
STAD	OS	Tertile	III,IV	0.162	0.511	.036	9	view →
LGG	DFS	Tertile	All	0.494	0.827	.046	9	view →
KIRP	OS	Tertile	All	0.361	0.730	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR4F14P–ESCA (OS)

Open the ESCA breakdown →